Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS.
about
Metabolic disorders in menopausePolycystic ovary syndrome: clinical implication in perimenopauseA life course perspective on polycystic ovary syndromeHealth and fertility in World Health Organization group 2 anovulatory womenScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Reactive oxygen species: players in the cardiovascular effects of testosteroneHyperandrogenic oligomenorrhea and metabolic risks across menopausal transitionReduced estradiol-induced vasodilation and poly-(ADP-ribose) polymerase (PARP) activity in the aortas of rats with experimental polycystic ovary syndrome (PCOS).Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-AnalysisWhite Matter Microstructure and Cognitive Function in Young Women With Polycystic Ovary Syndrome.Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.Polycystic ovary syndrome in 2011: Genes, aging and sleep apnea in polycystic ovary syndrome.Polycystic ovary syndrome: a common but often unrecognized condition.Cardiovascular and metabolic risks associated with PCOS.Polycystic ovaries - beyond menopause.Suitability of the National Health Care Surveys to Examine Behavioral Health Services Associated with Polycystic Ovary Syndrome.Cerebral white matter lesions and silent cerebral infarcts in postmenopausal women with polycystic ovary syndrome.Cardiovascular disease in polycystic ovary syndrome.Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.Bone markers in polycystic ovary syndrome: A multicentre study.
P2860
Q26795571-582E553F-8F28-4C53-BFC7-70AB899EF7FAQ26795581-E40BA9AC-82D7-4364-9B87-B824855DA3F1Q27026536-485E2951-44C7-4955-9374-422744394B59Q27026624-7D081303-9CC6-4AAE-8FE9-26B2D3B349BAQ28390200-37316A43-DBC2-47E0-9C86-B0A84BCC79C6Q28602465-CA864208-3756-43B7-90C9-2930A7F6ECBCQ33682425-DDE9DCB5-6B9A-44ED-BC91-57E70414149BQ34650147-6F37E34F-D286-467A-9A47-34D8BD520269Q35810003-BD644A5F-09B0-425B-AEB9-AE934A4BFF4FQ36431622-3CD91D68-0163-40A3-A8B7-AA000DDEACE6Q37361766-907B4815-E3E3-4368-83B6-5BBB801A732EQ37969922-83206A4C-1E51-49BF-9204-D1E7CD4CE8C1Q38010787-DD039F9B-798A-458B-BD3A-78D79C1939C5Q38089651-9C3B94C9-A389-4F50-B2F8-A66E5D7515D5Q38124922-095F2720-7C57-477C-BD9C-79D90E002AFFQ39103100-D6218D1F-3537-49A3-A2B0-9D6CB7959FDDQ40872641-1054AC50-9793-4CF9-8DD3-D3AF281B3211Q43543342-0519B4AF-719E-4B48-AA69-60E21E0BD3ACQ43739691-5F8E16B1-542D-4B48-8734-488FE5133E5DQ48169216-9B9EAA64-B269-4ADB-B7C2-8DEC7FB6FDA7
P2860
Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Unfavorable hormonal, metaboli ...... menopause in women with PCOS.
@en
Unfavorable hormonal, metaboli ...... menopause in women with PCOS.
@nl
type
label
Unfavorable hormonal, metaboli ...... menopause in women with PCOS.
@en
Unfavorable hormonal, metaboli ...... menopause in women with PCOS.
@nl
prefLabel
Unfavorable hormonal, metaboli ...... menopause in women with PCOS.
@en
Unfavorable hormonal, metaboli ...... menopause in women with PCOS.
@nl
P2093
P356
P1476
Unfavorable hormonal, metaboli ...... r menopause in women with PCOS
@en
P2093
Aimo Ruokonen
Antti Perheentupa
Ilkka Järvelä
Johanna Puurunen
Juha S Tapanainen
Laure Morin-Papunen
P304
P356
10.1210/JC.2011-0039
P407
P577
2011-03-30T00:00:00Z